A Pilot Study For Using Radiosurgery On Limited Metastases
In this research study high dose stereotactic body radiation therapy will be directed at the
site of metastasis. This treatment will be given once a day, 5 times a week (Monday through
Friday) for one to four weeks depending on the location and size of the disease to be
treated. Blood for the cytokine tests will be drawn before your therapy starts, weekly
during therapy and at the follow-up visits as stated in the next paragraphs. Two to four
tablespoons of blood will be removed each time.
Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
To determine the feasibility and potential utility of radiosurgery for limited metastatic disease, compared to historical controls.
Paul Okunieff, MD
University of Rochester
United States: Institutional Review Board
|University of Rochester Department of Radiation Oncology||Rochester, New York 14642|